NasdaqGM - Nasdaq Real Time Price USD
Wave Life Sciences Ltd. (WVE)
At close: October 22 at 4:00 PM EDT
Pre-Market: 8:00 AM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Cash Flow
-128,596.00
-19,431.00
-127,781.00
-88,993.00
-115,982.00
--
Investing Cash Flow
-1,023.00
-1,115.00
-1,255.00
-560.00
-1,338.00
--
Financing Cash Flow
110,795.00
132,534.00
67,188.00
55,828.00
154,538.00
--
End Cash Position
157,818.00
204,050.00
92,157.00
154,215.00
188,148.00
--
Capital Expenditure
-1,023.00
-1,115.00
-1,361.00
-560.00
-1,338.00
--
Issuance of Capital Stock
109,475.00
131,277.00
52,325.00
54,970.00
153,626.00
--
Free Cash Flow
-129,619.00
-20,546.00
-129,142.00
-89,553.00
-117,320.00
--
12/31/2019 - 11/11/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
KRRO Korro Bio, Inc.
70.02
-7.70%
ATNF 180 Life Sciences Corp.
4.6900
-5.63%
PRQR ProQR Therapeutics N.V.
3.7800
-6.67%
FOLD Amicus Therapeutics, Inc.
11.87
-1.17%
GRI GRI Bio, Inc.
0.9700
-26.52%
BIVI BioVie Inc.
3.3600
+27.76%
TPST Tempest Therapeutics, Inc.
1.0500
0.00%
TVGN Tevogen Bio Holdings Inc.
1.6100
-10.56%
GNPX Genprex, Inc.
3.5900
+137.75%
BDRX Biodexa Pharmaceuticals Plc
6.24
+4.35%